Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Jalid Sehouli, Prof. Dr.
CONTACT
Radoslav Chekerov, Dr.
CONTACT
Lead
JSehouli
With
This study is a prospective single-arm, open-label, multicenter phase I/II trial. The phase I-trial is a dose-escalation trial to determine the maximum tolerated dose (MTD) of pazopanib in combination with weekly topotecan. The phase II-trial is a single arm open-label trial to further assess the safety and the efficacy of this combination of treatment.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
